243 related articles for article (PubMed ID: 31028175)
1. Loss of the p53 transactivation domain results in high amyloid aggregation of the Δ40p53 isoform in endometrial carcinoma cells.
Melo Dos Santos N; de Oliveira GAP; Ramos Rocha M; Pedrote MM; Diniz da Silva Ferretti G; Pereira Rangel L; Morgado-Diaz JA; Silva JL; Rodrigues Pereira Gimba E
J Biol Chem; 2019 Jun; 294(24):9430-9439. PubMed ID: 31028175
[TBL] [Abstract][Full Text] [Related]
2. Effects of Δ40p53, an isoform of p53 lacking the N-terminus, on transactivation capacity of the tumor suppressor protein p53.
Hafsi H; Santos-Silva D; Courtois-Cox S; Hainaut P
BMC Cancer; 2013 Mar; 13():134. PubMed ID: 23514281
[TBL] [Abstract][Full Text] [Related]
3. p53 TAD2 Domain (38-61) Forms Amyloid-like Aggregates in Isolation.
Gadhave K; Kapuganti SK; Mishra PM; Giri R
ACS Chem Neurosci; 2022 Aug; 13(15):2281-2287. PubMed ID: 35856925
[TBL] [Abstract][Full Text] [Related]
4. Amyloidogenicity of p53: a hidden link between protein misfolding and cancer.
Gong H; Yang X; Zhao Y; Petersen RB; Liu X; Liu Y; Huang K
Curr Protein Pept Sci; 2015; 16(2):135-46. PubMed ID: 25692950
[TBL] [Abstract][Full Text] [Related]
5. Dominant effects of Δ40p53 on p53 function and melanoma cell fate.
Takahashi R; Markovic SN; Scrable HJ
J Invest Dermatol; 2014 Mar; 134(3):791-800. PubMed ID: 24037342
[TBL] [Abstract][Full Text] [Related]
6. The N-terminally truncated p53 isoform Δ40p53 influences prognosis in mucinous ovarian cancer.
Hofstetter G; Berger A; Berger R; Zorić A; Braicu EI; Reimer D; Fiegl H; Marth C; Zeimet AG; Ulmer H; Moll U; Zeillinger R; Concin N
Int J Gynecol Cancer; 2012 Mar; 22(3):372-9. PubMed ID: 22246403
[TBL] [Abstract][Full Text] [Related]
7. [Effect of Δ40p53 isoform on enhancing the pro-apoptotic function of p53 in tumor cells].
Wang BS; Zhao HW; Qiao LX; Shan JQ; Hou QS; Chen DX; Guo HL
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):332-338. PubMed ID: 28535648
[No Abstract] [Full Text] [Related]
8. Expression of p53 N-terminal isoforms in B-cell precursor acute lymphoblastic leukemia and its correlation with clinicopathological profiles.
Oh L; Hainaut P; Blanchet S; Ariffin H
BMC Cancer; 2020 Feb; 20(1):110. PubMed ID: 32041553
[TBL] [Abstract][Full Text] [Related]
9. G-quadruplex structures in TP53 intron 3: role in alternative splicing and in production of p53 mRNA isoforms.
Marcel V; Tran PL; Sagne C; Martel-Planche G; Vaslin L; Teulade-Fichou MP; Hall J; Mergny JL; Hainaut P; Van Dyck E
Carcinogenesis; 2011 Mar; 32(3):271-8. PubMed ID: 21112961
[TBL] [Abstract][Full Text] [Related]
10. Post-translational regulation of p53 function through 20S proteasome-mediated cleavage.
Solomon H; Bräuning B; Fainer I; Ben-Nissan G; Rabani S; Goldfinger N; Moscovitz O; Shakked Z; Rotter V; Sharon M
Cell Death Differ; 2017 Dec; 24(12):2187-2198. PubMed ID: 28885617
[TBL] [Abstract][Full Text] [Related]
11. p53 reactivation with induction of massive apoptosis-1 (PRIMA-1) inhibits amyloid aggregation of mutant p53 in cancer cells.
Rangel LP; Ferretti GDS; Costa CL; Andrade SMMV; Carvalho RS; Costa DCF; Silva JL
J Biol Chem; 2019 Mar; 294(10):3670-3682. PubMed ID: 30602570
[TBL] [Abstract][Full Text] [Related]
12. Δ40p53 isoform up-regulates netrin-1/UNC5B expression and potentiates netrin-1 pro-oncogenic activity.
Sun Y; Manceau A; Frydman L; Cappuccio L; Neves D; Basso V; Wang H; Fombonne J; Maisse C; Mehlen P; Paradisi A
Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34470826
[TBL] [Abstract][Full Text] [Related]
13. Distinct modulatory role of RNA in the aggregation of the tumor suppressor protein p53 core domain.
Kovachev PS; Banerjee D; Rangel LP; Eriksson J; Pedrote MM; Martins-Dinis MMDC; Edwards K; Cordeiro Y; Silva JL; Sanyal S
J Biol Chem; 2017 Jun; 292(22):9345-9357. PubMed ID: 28420731
[TBL] [Abstract][Full Text] [Related]
14. Expanding the prion concept to cancer biology: dominant-negative effect of aggregates of mutant p53 tumour suppressor.
Silva JL; Rangel LP; Costa DC; Cordeiro Y; De Moura Gallo CV
Biosci Rep; 2013 Jul; 33(4):. PubMed ID: 24003888
[TBL] [Abstract][Full Text] [Related]
15. Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: implications for cancer.
Ano Bom AP; Rangel LP; Costa DC; de Oliveira GA; Sanches D; Braga CA; Gava LM; Ramos CH; Cepeda AO; Stumbo AC; De Moura Gallo CV; Cordeiro Y; Silva JL
J Biol Chem; 2012 Aug; 287(33):28152-62. PubMed ID: 22715097
[TBL] [Abstract][Full Text] [Related]
16. The translation initiation factor DAP5 promotes IRES-driven translation of p53 mRNA.
Weingarten-Gabbay S; Khan D; Liberman N; Yoffe Y; Bialik S; Das S; Oren M; Kimchi A
Oncogene; 2014 Jan; 33(5):611-8. PubMed ID: 23318444
[TBL] [Abstract][Full Text] [Related]
17. Δ40p53 is involved in the inactivation of autophagy and contributes to inhibition of cell death in HCT116-Δ40p53 cells.
Zang Y; Shi Y; Liu K; Qiao L; Guo X; Chen D
Oncotarget; 2017 Feb; 8(8):12754-12763. PubMed ID: 28061446
[TBL] [Abstract][Full Text] [Related]
18. p53 isoform expression promotes a stemness phenotype and inhibits doxorubicin sensitivity in breast cancer.
Steffens Reinhardt L; Groen K; Zhang X; Morten BC; Wawruszak A; Avery-Kiejda KA
Cell Death Dis; 2023 Aug; 14(8):509. PubMed ID: 37553320
[TBL] [Abstract][Full Text] [Related]
19. The Δ40p53 isoform inhibits p53-dependent eRNA transcription and enables regulation by signal-specific transcription factors during p53 activation.
Levandowski CB; Jones T; Gruca M; Ramamoorthy S; Dowell RD; Taatjes DJ
PLoS Biol; 2021 Aug; 19(8):e3001364. PubMed ID: 34351910
[TBL] [Abstract][Full Text] [Related]
20. The "LINC" between Δ40p53-miRNA Axis in the Regulation of Cellular Homeostasis.
Pal A; Ghosh PK; Das S
Mol Cell Biol; 2023; 43(7):335-353. PubMed ID: 37283188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]